The present study demonstrates that preoperative levels of IGF-I or IGFBP-3 (tertiles) are positively associated with risk of breast cancer recurrence, which is in contrast to a recent study of Danish postmenopausal patients (28). This evidence concerns the gene IGF1 and breast cancer.